全文获取类型
收费全文 | 265篇 |
免费 | 11篇 |
国内免费 | 47篇 |
出版年
2023年 | 5篇 |
2022年 | 14篇 |
2021年 | 20篇 |
2020年 | 17篇 |
2019年 | 20篇 |
2018年 | 14篇 |
2017年 | 7篇 |
2016年 | 12篇 |
2015年 | 14篇 |
2014年 | 27篇 |
2013年 | 17篇 |
2012年 | 24篇 |
2011年 | 28篇 |
2010年 | 14篇 |
2009年 | 15篇 |
2008年 | 22篇 |
2007年 | 10篇 |
2006年 | 5篇 |
2005年 | 4篇 |
2004年 | 6篇 |
2003年 | 7篇 |
2002年 | 4篇 |
1999年 | 4篇 |
1998年 | 1篇 |
1997年 | 3篇 |
1996年 | 3篇 |
1995年 | 3篇 |
1993年 | 1篇 |
1991年 | 2篇 |
排序方式: 共有323条查询结果,搜索用时 562 毫秒
61.
62.
6-羟多巴胺纹状体内注射制作大鼠帕金森病模型的研究 总被引:11,自引:0,他引:11
目的 为拓宽6-OHDA损毁多巴胺能神经元所制备大鼠帕金森病模型的应用范围,采用多位点纹状体内注入6-OHDA的途径来制备模型。方法 研究用SD大鼠,两个针道内四点定位注射,每点注射3μg/μ16-OHDA3μl。结果 术后两周出现缓慢旋转,4周旋转行为达到7转/分并保持稳定;形态学染色可见损毁1周后注射侧黑质酪氨酸羟化酶免疫组化阳性细胞减少20%,2周后减少38%,3~4周减少70%以上,6周后损伤趋缓。高效液相-电化学法活体检测纹状体内多巴胺的代谢产物3、4-二羟基苯乙酸(DOPAC)和高香草酸(HVA),发现注射侧和非注射侧相比含量分别下降98.33%和96.05%;组织匀浆检测损毁侧黑质多巴胺含量下降了73%以上,3、4-二羟基苯乙酸(DOPAC)含量下降60%。结论 纹状体内注射6-OHDA能够制备帕金森病大鼠模型。 相似文献
63.
Chunli Zheng Jiti Zhou Jing Wang Baocheng Qu Jing Wang Hong Lu Hongxia Zhao 《Bioresource technology》2009,100(6):2082-2084
Streptomyces sp. Z2 was isolated from nitrobenzene contaminated activated sludge, which utilized nitrobenzene as a sole source of carbon, nitrogen, and energy under aerobic condition. It was found that besides nitrobenzene strain Z2 can degrade 2-picolinic acid. Strain Z2 completely degraded 2-picolinic acid with initial concentration of 500 mg/L, 1000 mg/L, 1500 mg/L, 2000 mg/L, 2500 mg/L, and 3000 mg/L within 36 h, 50 h, 72 h, 100 h, 136 h, and 180 h, respectively. Kinetics of 2-picolinic acid degradation was described using the Andrews equation. The kinetic parameters were as follows: qmax = 3.81 h?1, Ks = 83.10 mg/L, and Ki = 252.11 mg/L. During the biodegradation process, Z2 transformed 2-picolinic acid into a product which was identified as 6-hydroxy picolinic acid by UV–vis spectrometry, 1H nuclear magnetic resonance spectroscopy, and mass spectrometry. 6-Hydroxy picolinic acid was then cleaved and mineralized with release of ammonia. 相似文献
64.
65.
摘要: 【目的】构建产气荚膜梭菌(Clostridium perfringens, C.perfringens)α 毒素基因的重组干酪乳杆菌口服疫苗,为产气荚膜梭菌毒素中毒的防治提供有效方法。【方法】将构建的重组产气荚膜梭菌α毒素基因细胞表面型载体pPG1及分泌表达载体pPG2电转化乳酸乳杆菌(Lactobacillus casei L.casei),获得阳性重组菌pPG1-α/ L.casei 393 乳酸乳杆菌表面表达系统和pPG2-α/ L.casei393乳酸乳杆菌分泌表达系统。重组菌以1%乳糖为诱导物,在MRS培养基中进行诱导,通过Western-blot和间接免疫荧光方法鉴定,确定目的蛋白的表达。将重组菌口服免疫BALB/c小鼠,收集免疫小鼠粪便及眼冲洗液及外生殖道黏液样本测定小鼠产生抗α毒素的特异性sIgA 抗体水平,采集小鼠血液样本测定血清中抗α毒素的特异性IgG抗体水平。并对免疫小鼠进行α毒素的腹腔攻毒实验及对获得的抗血清进行α毒素中和试验测定。【结果】重组干酪乳杆菌pPG1-α/ L.casei 393及pPG2-/ L.casei 393免疫小鼠能够产生明显的抗α毒素的sIgA 和IgG 抗体水平,其对α毒素中和试验结果为完全保护。腹腔攻毒实验结果为能抵抗3倍最小致死剂量的α毒素攻击。【结论】表达产气荚膜梭菌α毒素免疫保护性抗原的重组乳酸乳杆菌口服免疫动物能够产生良好的局部和系统体液免疫应答和免疫中和效力。 相似文献
66.
67.
68.
Dexing Ma Chunli Ma Long Pan Guangxing Li Jinghong Yang Jiehua Hong Haofan Cai Xiaofeng Ren 《Experimental parasitology》2011,(1):208-214
Eimeria acervulina 3-1E antigen gene and mature chicken interleukin 15 (mChIL-15) gene were cloned into expression vector pcDNA3.1(+) in different forms, produced DNA vaccine pcDNA3.1-3-1E, and pcDNA3.1-3-1E-linker-mChIL-15 co-expressing E. acervulina 3-1E gene and mChIL-15 gene, respectively. The expression of objective gene in vitro was detected by indirect fluorescent antibody technique and immunohistochemistry. The two DNA vaccines were administered by intramuscular leg injection. An animal challenge experiment was carried out to evaluate the immune protective efficacy of the vaccines. The results indicated that DNA vaccines were successfully constructed and the expression of objective gene could be detected in vitro. The animal experimental results showed that both DNA vaccines could provide partial protection against homologous challenge in chickens. The chimeric DNA vaccine, pcDNA3.1-3-1E-linker-mChIL-15, could significantly increase oocyst decrease ratio, reduce the average lesion score in the duodenum, improve body weight gain, and increase anti-coccidial index (ACI) compared to the DNA vaccine pcDNA3.1-3-1E. Taken together, these results demonstrate ChIL-15 enhance the immunogenicity of 3-1E DNA vaccine, and co-expression of cytokine and optimized surface antigen of Eimeria may be a promising method to enhance immunogenicity of DNA vaccines in poultry. 相似文献
69.
构建SPARc基因过表达载体,转染人骨髓增生异常综合征(myelodysplastic syndrome,MDS)-u/胞系SKM-1细胞,探讨SPARc基因过表达对!&MDS细胞系SKM一1细胞凋亡的影响。XpcD—NA.SPARC为引物,PCR扩增SPARc基因;将靶基因克隆入慢病毒载体pGC—GV,构建含有删Rc基因的重组慢病毒载体pGC—GV-SPARC,测序检测正确性;将构建载体pGC-GV-5黝尺C砗专染人MDs细胞系SKM-1,流式细胞术检测转染效率,RT-PCR检测sKM-1细胞中SPARCmRNA表达,Westernblot检测SPARC蛋白表达,MTS法测定小剂量阿糖胞苷(30ng/mL)对实验组增殖抑制的影响,AnnexinV检测.洲尺c基因转染后对人SKM-1细胞凋亡的影响。结果显示,构建含有SPARc基因的重组慢病毒载体pGC-GV-SPARC转染效率为(64.25±1.42)%;转染后,SPARCmRNA及蛋白表达在靶细胞中较对照组增多。小剂量阿糖胞苷对转染组的增殖抑制率明显高于其他组。SPARC基因转染后人SKM-1细胞凋亡率较未转染组明显增高,加入阿糖胞苷后人SKM-1细胞凋亡率较对照组明显增高。由此说明,作者成功构建了携带.&SPARc基因的慢病毒载体,转染.NSKM-1细胞系后稳定表达SPARC基因,SPARC过表达可抑制细胞增殖,且联合小剂量阿糖胞苷(30ng/mL)更有效地抑制SKM-1细胞的增殖,并诱导其凋亡。 相似文献
70.
Bing Tan Jinxiang Tan Hongfei Du Zhen Quan Xiangdong Xu Xiaoliang Jiang Chunli Luo Xiaohou Wu 《Molecular and cellular biochemistry》2014,385(1-2):95-102
p62/sequestosome-1 is a multifunctional adapter protein implicated in selective autophagy, cell signaling pathways, and tumorigenesis, and plays an important role at the crossroad between autophagy and cancer. But, the connection between autophagy and cancer is complex and in some cases contradictory. Human colorectal cancer tissues from patients were analyzed for expression of p62 and Microtubule-associated protein light chain 3 (LC3, an autophagosome marker) using immunostaining, western blotting, real-time PCR, and confocal microscopy. To study the effects of p62 on autophagy and cell growth, shRNA for p62 was applied and cell growth curve was monitored in human colorectal cancer cell. In vivo experiments were done using the mouse xenograft model. We showed that up-regulated expression of p62 and LC3 in colorectal cancer tissues. We also demonstrated that specifically knockdown the expression of p62 showed significantly inhibitory effects not only on autophagy activation, but also on tumor growth both in vitro and xenograft tumors model. The ectopic overexpression of p62 and autophagy activation contributes to colorectal tumorigenesis. p62 and autophagy will be therapy targets for the treatment of colorectal cancer. 相似文献